AI Strategy & Roadmap in Bethesda, MD

Bethesda sits at an unusual intersection: one of the highest concentrations of life-sciences and healthcare-IT talent on the East Coast, a corridor of financial services professionals, and Marriott International's global headquarters. The AI consulting questions that surface here are not generic. A biotech spin-out four blocks from the NIH campus needs to know whether clinical-trial document automation is a build, a buy, or a compliance landmine before committing budget. A healthcare-IT firm serving hospital networks needs a credible build-vs-buy analysis on patient-communication workflows that accounts for HIPAA architecture constraints, not a vendor demo deck. A Marriott-adjacent hospitality operator needs to understand where AI in revenue management, guest operations, or procurement actually moves margin — and where the off-the-shelf tools already cover it adequately.

AI strategy consulting in this market demands a certain level of sector specificity. A generic roadmap framework that works for a SaaS company in Austin will produce bad answers for a Phase II biotech in Bethesda. The regulatory surface area is different, the data architecture constraints are different, and the build-vs-buy calculus is different when the "buy" option is an FDA-cleared software product versus a configurable SaaS workflow tool.

What the roadmap engagement actually produces for Bethesda clients: a structured intake covering your current stack, team capacity, and the one or two outcomes that would move the business materially. From there, a facilitated workshop — two days or two weeks depending on complexity — maps leverage points across your specific operational workflows. Each candidate capability gets scored against effort, realistic revenue or cost impact, and relevant regulatory or ethical risk. The top three get a written build-vs-buy breakdown. The output is a Phase 1 scope brief your team can hand to any implementation partner, including us, without a follow-on dependency.

Most Bethesda operators who reach out to Golden Horizons have already been through vendor demo cycles. The pattern is familiar: a software company presents a polished AI capability, the team is interested, and then no one has a clear answer on whether this is the right first build, whether internal data is in good enough shape to support it, or whether a competing SaaS product already solves the problem for a fraction of the custom-build cost. The roadmap engagement exists to answer those questions before money moves.

Starting point is the $99 AI readiness audit — a structured diagnostic that maps your current stack, surfaces the workflows where AI is most likely to move a business number, and identifies the data and integration constraints that will shape every decision downstream. For Bethesda clients in regulated industries, the audit also flags the compliance architecture questions that need answering before any build scoping begins. That report is typically the first document in an executive or board-level conversation that has previously been stuck at the level of vendor pitches.

From the audit, two paths. If the audit surfaces a clear high-leverage candidate — a specific workflow with a defined owner, a realistic data foundation, and a measurable outcome — we scope a fixed-price roadmap engagement: two-day workshop or two-week deep dive, vendor-neutral deliverable, no retainer attached. If priorities are genuinely unclear or there are multiple competing candidates across different business units, the $497 Founder Review Call is ninety minutes with the founder directly, covering the top three to five candidates in ranked order with a written prioritization memo at the close. No junior consultants, no follow-up slide deck — a working document your team can act on.

The roadmap deliverable is a Phase 1 scope brief: specific enough that any builder can execute against it, honest enough that build-vs-buy decisions don't get reversed three months into implementation when the real constraints surface. Bethesda clients in life sciences and healthcare-IT have found this particularly useful because the scope brief includes the regulatory and compliance architecture notes that commercial AI vendors rarely document clearly before a contract is signed.